| IA | COVID-19 | P |
---|---|---|---|
Blood routine(n = 59) | |||
 Lymphocytes | |||
  Count(×109/L) | 1.8 (1.0–3.4) | 3.2 (1.8–5.0) | < 0.01 |
  Percentage (%) | 26.0 (12.0–44.0) | 50.4 (36.6–68.6) | < 0.01 |
 Neutrophils | |||
  Count (×109/L) | 4.2 (2.8–7.7) | 2.2 (1.4–4.1) | < 0.01 |
  Percentage (%) | 62.0 (43.0–78.0) | 37.7 (21.5–49.1) | < 0.01 |
 Hemoglobin (g/L) | 112.0 (101.0–123.0) | 123.0 (111.0–128.0) | < 0.01 |
 Neutrophil-to-lymphocyte ratio | 2.6 (0.9–7.1) | 0.7 (0.3–1.4) | < 0.01 |
Coagulation function(n = 51) | |||
 Activated partial thromboplastin time (s) | 42.4 (38.7–46.3) | 35.2 (30.9–40.5) | < 0.01 |
 Prothrombin time (s) | 14.0 (12.7–15.1) | 11.6 (10.7–12.8) | < 0.01 |
Blood biochemistry | |||
 Albumin (g/L) (n = 61) | 42.0 (39.9–43.6) | 44.2 (42.1–46.7) | < 0.01 |
 C-reactive protein (mg/L) (n = 61) | 5.8 (1.2–20.6) | 0.9 (0.8–5.0) | < 0.01 |
 Procalcitonin (ng/mL) (n = 44) | 0.4 (0.2–1.0) | 0.1 (0.1–0.1) | < 0.01 |